Title
Category
Credits
Event date
Cost
  • Primary Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. Sexual minority youth report stigmatization and negative reactions from healthcare providers when disclosing LGBTQIA+ status. Practice how to start the conversation through case discussion in an interactive learning module on LGBTQIA+ health. Focus group methodology was used to develop themes for module content: appropriate terminology, health disparities and interactive cases to demonstrate respectful communication about gender identity and sexual orientation. Participants will receive a toolbox of resources on caring for LGBTQIA+ youth.
  • Primary Care
  • Acute Care
  • Contact hours
$25.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 12.5$ for NAPNAP Members. For non- members, this continuing education activity rate is 25$. This presentation will describe the steps of pediatric GU exam, list normal vs. concerning GU variants, and define treatment recommendations and guidelines for pediatric victims of sexual assault.
  • Primary Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. This presentation will describe the planning process for the development of a direct to consumer telehealth offering for minor illnesses and injuries including the business plan, staffing model, location, EMR documentation development and education. It will also discuss the ongoing work that is occurring and the expansion of the service line that occurred with COVID-19. Finally, the presenter will review the ongoing work as we continue to learn moving forward into the future of telehealth and pediatrics including what the advance practice provider can offer with their expertise.
  • Primary Care
  • Nutrition/Feeding
  • Contact hours
$10.00
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. A recent publication was released with new guidelines to early introduction of foods to prevent food allergies. Dr. Shroba, who previously presented on the Food Allergy Prevention course will update you on the most important facts of this new research. You will be able to asses infant’s levels of risk for development of a food allergy. You will also learn how to counsel parents on timing and available options and approaches for introduction of allergenic foods.
  • Primary Care
  • Nutrition/Feeding
  • Contact hours
$20.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Baby Friendly Hospital Initiatives help to improve exclusive breastfeeding initiation but continued support is needed to maintain breastfeeding rates post discharge.  This course discusses why a lactation service should be imbedded in the primary care setting. The student will learn the steps to become a breastfeeding office, design a lactation service and how to implement the service into your company as well as study the impact of the service using the electronic medical record after it is in place. This course is supported by the Breastfeeding Education Special Interest Group (BFE).
  • Primary Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Penicillin allergy, the most commonly reported allergy in a pediatric patient, is associated with increases in cost of care, hospitalization and morbidity, as well as contributing to antibiotic resistance. However, 95% of patients labeled with a penicillin allergy do not have a true allergy. The Centers for Disease Control & Prevention has identified improper use of antibiotics to be an important factor that must be addressed for both patient safety and public health. This presentation will identify high-risk symptoms of allergy, differentiate between adverse reactions, IgE-mediated allergic reaction and delayed T-cell reactions, as well as discuss appropriate testing for penicillin allergy. Additionally, the presenter will address alternative antibiotics that can be used until a formal allergy evaluation can be completed.
  • Primary Care
  • Mental Health
  • TeamPeds Talks
  • Contact hours
$0.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. TeamPeds Talks will focus on Mental Health in our second Conversations on Child Health series. This conversation episode's guest is Jennifer Hannon DNP, ARNP, CPNP-PC, PMHS, discussing Importance of Sleep. In this episode, Dr. Hannon shares tips for healthy sleep habits for teens, and its connection to wellbeing and mental health. Listen as she shares with Dr. Peck about how to recognize signs of disordered sleep and what to do about them.
  • Primary Care
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
  • Contact hours
$10.00
0.5 contact hour of which 0.5 contain pharmacology content and 0.5 controlled substances.This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Urine drug screening (UDS) is a laboratory test frequently used to screen for drugs of abuse, monitor for medication compliance, evaluate for suspected drug intoxication or overdose, and in office-based pain contracts (Kale, 2019; Standridge, Adams, & Zotos, 2010). In children and adolescents,UDS may be used to prevent substance use, evaluate for suspected drug use or intoxication, or as part of substance abuse treatment (Levy & Siqueira, 2014). When using UDS as a tool to make clinical decisions about high-risk medications, it is important to understand the differences between UDS testing modalities, common causes of falsepositive or false-negative results, and the detection window of specific medications. There are two commonly used types of UDS available: immunoassay and gas chromatography/ mass spectrometry (GC-MS; Kale, 2019).
  • Primary Care
  • Mental Health
  • TeamPeds Talks
  • Contact hours
$0.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. TeamPeds Talks will focus on Mental Health in our second Conversations on Child Health series. This episode's guest is Laura Searcy MSN, PPCNP-BC, discussing Substance Use. In this episode, pediatric nurse practitioner and nationally recognized expert Laura Searcy shares the current risks for teens using alcohol, marijuana, nicotine, and other substances. Join us for effective strategies to help keep developing teen brains chemical free.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Psychopharmacology CE
$125.00
7.0 NAPNAP Pharmacology Contact Hour, and 0.75 Psychopharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $55 for NAPNAP Members. For non- members, this continuing education activity rate is $125. Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits, as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Drugs abused by adolescents, nutraceuticals used with children, updates on treatment guidelines and changes in drug labeling will be also reviewed.

Pages